Able Wealth Management LLC Akero Therapeutics, Inc. Transaction History
Able Wealth Management LLC
- $110 Billion
- Q4 2023
A detailed history of Able Wealth Management LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Able Wealth Management LLC holds 34 shares of AKRO stock, worth $754. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34Holding current value
$754% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
193Shares Held
74.2MCall Options Held
429KPut Options Held
591K-
Janus Henderson Group PLC London, X06.12MShares$136 Million0.09% of portfolio
-
Rtw Investments, LP New York, NY5.43MShares$121 Million2.2% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$116 Million3.09% of portfolio
-
Wellington Management Group LLP Boston, MA5.21MShares$116 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.89MShares$109 Million0.0% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.03B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...